Open AccessThis article is
- freely available
The Impact of Residual Symptoms in Major Depression
San Francisco VA Medical Center, University of California San Francisco, 4150 Clement Street, 116N, San Francisco, CA 94121, USA
Received: 30 June 2010; in revised form: 2 July 2010 / Accepted: 22 July 2010 / Published: 3 August 2010
Abstract: The current definition of remission from major depressive disorder does not fully take into account all aspects of patient recovery. Residual symptoms of depression are very common in patients who are classified as being in remission. Patients with residual symptoms are at increased risk of functional and interpersonal impairments, and are at high risk for recurrence of depression. This article discusses the incidence of residual symptoms of depression, as well as the risks and consequences of these symptoms, and will review the state of current treatment.
Keywords: major depressive disorder, MDD, antidepressive agents, residual symptoms, depression, depression treatment
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Israel, J.A. The Impact of Residual Symptoms in Major Depression. Pharmaceuticals 2010, 3, 2426-2440.
Israel JA. The Impact of Residual Symptoms in Major Depression. Pharmaceuticals. 2010; 3(8):2426-2440.
Israel, Joshua A. 2010. "The Impact of Residual Symptoms in Major Depression." Pharmaceuticals 3, no. 8: 2426-2440.